5.5 Pancreas and glucose regulation

The pancreas plays a crucial role in glucose regulation, balancing blood sugar levels through the hormones insulin and glucagon. These hormones work together to maintain homeostasis, with insulin lowering blood glucose and glucagon raising it when needed.

Understanding pancreatic function is key to grasping endocrine system dynamics. Diabetes, a common disorder of glucose regulation, highlights the importance of this organ in maintaining overall health and well-being.

Pancreas Anatomy and Structure

Location and Relationship to Other Organs

Top images from around the web for Location and Relationship to Other Organs

• 

  The Pancreas, Pineal Gland, and Gonads | Biology for Majors II View original

  Is this image relevant?

• 

  Accessory Organs in Digestion: The Liver, Pancreas, and Gallbladder · Anatomy and Physiology View original

  Is this image relevant?

• 

  Parts of the Digestive System | Biology for Majors II View original

  Is this image relevant?

• 

  The Pancreas, Pineal Gland, and Gonads | Biology for Majors II View original

  Is this image relevant?

• 

  Accessory Organs in Digestion: The Liver, Pancreas, and Gallbladder · Anatomy and Physiology View original

  Is this image relevant?

1 of 3

Top images from around the web for Location and Relationship to Other Organs

• 

  The Pancreas, Pineal Gland, and Gonads | Biology for Majors II View original

  Is this image relevant?

• 

  Accessory Organs in Digestion: The Liver, Pancreas, and Gallbladder · Anatomy and Physiology View original

  Is this image relevant?

• 

  Parts of the Digestive System | Biology for Majors II View original

  Is this image relevant?

• 

  The Pancreas, Pineal Gland, and Gonads | Biology for Majors II View original

  Is this image relevant?

• 

  Accessory Organs in Digestion: The Liver, Pancreas, and Gallbladder · Anatomy and Physiology View original

  Is this image relevant?

1 of 3

• The pancreas is a glandular organ situated in the upper left quadrant of the abdominal cavity
• It is positioned behind the stomach and adjacent to the duodenum, the first part of the small intestine
• The head of the pancreas is nestled in the C-shaped curve of the duodenum, while the tail extends towards the spleen (liver, gallbladder)

Anatomical Regions and Tissue Composition

• The pancreas is divided into three main regions: the head, body, and tail
• It is composed of two functionally distinct types of tissue: exocrine and endocrine
  • Exocrine tissue makes up the majority of the pancreas and secretes digestive enzymes into the duodenum via the pancreatic duct (amylase, lipase, trypsin)
  • Endocrine tissue consists of the pancreatic islets (islets of Langerhans) scattered throughout the pancreas

Pancreatic Islets and Cell Types

• The pancreatic islets contain three main types of endocrine cells: alpha cells, beta cells, and delta cells
  • Alpha cells secrete the hormone glucagon, which raises blood glucose levels
  • Beta cells secrete the hormone insulin, which lowers blood glucose levels
  • Delta cells secrete the hormone somatostatin, which regulates the secretion of both insulin and glucagon (paracrine action)
• The islets are highly vascularized, allowing the hormones to be readily secreted into the bloodstream

Endocrine Pancreas Hormones

Insulin: Secretion and Functions

• Insulin is secreted by the beta cells of the pancreatic islets in response to elevated blood glucose levels (after a meal)
• It is the primary anabolic hormone that promotes the storage and utilization of nutrients, particularly glucose
  • Stimulates glucose uptake into cells by promoting the translocation of glucose transporter proteins (GLUT4) to the cell membrane
  • Promotes the storage of glucose as glycogen in the liver and skeletal muscles
  • Inhibits glucose production by the liver (glycogenolysis and gluconeogenesis)
• Insulin also has effects on lipid and protein metabolism, promoting the storage of these nutrients (fatty acid synthesis, protein synthesis)

Glucagon: Secretion and Functions

• Glucagon is secreted by the alpha cells of the pancreatic islets in response to low blood glucose levels (fasting state)
• It is the primary catabolic hormone that mobilizes stored nutrients to raise blood glucose levels
  • Stimulates the breakdown of glycogen into glucose in the liver (glycogenolysis) and its release into the bloodstream
  • Promotes gluconeogenesis, the synthesis of new glucose molecules from non-carbohydrate precursors (amino acids, lactate, glycerol)
  • Enhances lipolysis in adipose tissue, releasing fatty acids for energy production (ketogenesis)

Somatostatin: Secretion and Functions

• Somatostatin is secreted by the delta cells of the pancreatic islets
• It acts as a paracrine regulator, inhibiting the secretion of both insulin and glucagon from neighboring alpha and beta cells
• This helps to fine-tune glucose regulation by preventing excessive secretion of these hormones
• Somatostatin also has inhibitory effects on the secretion of other gastrointestinal hormones (gastrin, cholecystokinin) and on gastrointestinal motility

Insulin and Glucagon Action

Insulin Signaling Pathway

• Insulin binds to insulin receptors on the surface of target cells, initiating a signaling cascade
• The activated insulin receptor phosphorylates insulin receptor substrate (IRS) proteins, which then activate downstream signaling pathways (PI3K/Akt pathway)
• This leads to the translocation of glucose transporter proteins (GLUT4) from intracellular vesicles to the cell membrane, facilitating glucose uptake into the cell (skeletal muscle, adipose tissue)
• In the liver, insulin activates glycogen synthase and inhibits glycogen phosphorylase, promoting the storage of glucose as glycogen
• Insulin also suppresses the expression of gluconeogenic enzymes (glucose-6-phosphatase, PEPCK), inhibiting hepatic glucose production

Glucagon Signaling Pathway

• Glucagon binds to glucagon receptors on liver cells, activating adenylate cyclase and increasing intracellular cyclic AMP (cAMP) levels
• Elevated cAMP activates protein kinase A (PKA), which phosphorylates and activates key enzymes involved in glucose mobilization
  • Glycogen phosphorylase is activated, promoting the breakdown of glycogen into glucose (glycogenolysis)
  • Gluconeogenic enzymes (glucose-6-phosphatase, PEPCK) are upregulated, increasing the synthesis of new glucose molecules
• PKA also phosphorylates and inactivates pyruvate kinase, diverting metabolites away from glycolysis and towards gluconeogenesis
• In adipose tissue, glucagon stimulates lipolysis, releasing fatty acids that can be used for energy production in the liver (ketogenesis)

Counterregulatory Actions and Glucose Homeostasis

• Insulin and glucagon have opposing actions on glucose metabolism, working together to maintain blood glucose levels within a narrow range (70-110 mg/dL)
• During the fed state, insulin promotes glucose storage and utilization, while suppressing glucose production
• During the fasting state, glucagon stimulates glucose mobilization and production, while insulin secretion is suppressed
• The balance between these two hormones is crucial for maintaining glucose homeostasis
• Other hormones, such as cortisol, growth hormone, and catecholamines, also have counterregulatory effects and can modulate insulin and glucagon action

Diabetes Mellitus Pathophysiology and Management

Types and Etiology of Diabetes Mellitus

• Diabetes mellitus is a group of metabolic disorders characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both
• Type 1 diabetes (T1D) is an autoimmune disorder in which the beta cells of the pancreas are destroyed, leading to absolute insulin deficiency
  • Usually presents in childhood or adolescence and accounts for 5-10% of diabetes cases
  • Genetic predisposition and environmental triggers (viral infections) play a role in its development
• Type 2 diabetes (T2D) is characterized by insulin resistance and relative insulin deficiency
  • Accounts for 90-95% of diabetes cases and is often associated with obesity, physical inactivity, and genetic factors
  • Insulin resistance leads to impaired glucose uptake and utilization, while beta cell dysfunction results in insufficient insulin secretion
• Gestational diabetes occurs during pregnancy due to hormonal changes that induce insulin resistance
  • Usually resolves after delivery but increases the risk of developing T2D later in life
  • Can lead to complications for both the mother (preeclampsia) and the fetus (macrosomia, neonatal hypoglycemia)

Complications of Diabetes Mellitus

• Chronic hyperglycemia in poorly controlled diabetes can lead to a wide range of complications
• Microvascular complications affect small blood vessels and include:
  • Retinopathy: damage to the retina, potentially leading to vision loss or blindness
  • Nephropathy: damage to the kidneys, leading to impaired renal function and end-stage renal disease
  • Neuropathy: damage to the nerves, causing sensory loss, pain, and autonomic dysfunction (gastroparesis, erectile dysfunction)
• Macrovascular complications affect large blood vessels and include:
  • Cardiovascular disease: increased risk of coronary artery disease, myocardial infarction, and stroke
  • Peripheral artery disease: impaired blood flow to the extremities, leading to poor wound healing and increased risk of amputations
• Other complications include increased susceptibility to infections, dental problems, and skin disorders (diabetic dermopathy)

Management of Diabetes Mellitus

• The goal of diabetes management is to maintain blood glucose levels within the target range and prevent or delay the development of complications
• For T1D, management involves lifelong insulin replacement therapy, either through multiple daily injections or continuous subcutaneous insulin infusion (insulin pump)
  • Patients must monitor their blood glucose levels regularly and adjust insulin doses accordingly
  • A balanced diet, regular physical activity, and stress management are also important aspects of T1D management
• For T2D, management initially focuses on lifestyle modifications, such as maintaining a healthy diet, engaging in regular physical activity, and achieving a healthy body weight
  • If lifestyle changes alone are insufficient, oral hypoglycemic agents (metformin, sulfonylureas, thiazolidinediones) may be prescribed to improve insulin sensitivity or stimulate insulin secretion
  • In advanced stages, insulin therapy may be necessary to achieve adequate glycemic control
• Regular monitoring of blood glucose levels, either through self-monitoring or continuous glucose monitoring systems, is crucial for assessing treatment efficacy and making necessary adjustments
• Patients with diabetes should also undergo regular screening for complications, such as annual eye exams, kidney function tests, and foot exams
• Education and support from healthcare professionals, including physicians, nurses, and diabetes educators, are essential for empowering patients to effectively manage their condition and maintain a high quality of life.